Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals business develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products business sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others business distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
Company profile
Ticker
OTSKF
Website
CEO
Tatsuo Higuchi
Employees
Location
SEC CIK
Latest filings (excl ownership)
F-6EF
Automatic registration for ADRs (foreign)
22 Nov 19
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
29 Sep 17
F-6EF
Automatic registration for ADRs (foreign)
16 Oct 14
F-6EF
Automatic registration for ADRs (foreign)
8 Apr 14
F-6EF
Automatic registration for ADRs (foreign)
16 Oct 12
F-6EF
Automatic registration for ADRs (foreign)
23 Aug 12
F-6EF
Automatic registration for ADRs (foreign)
16 Mar 12
Latest ownership filings
No filings
Institutional ownership, Q2 2023
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 398.61 mm |
Total shares | 10.58 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Pacer Advisors | 9.83 k | $370.36 mm |
Paradigm Asset Management | 750.00 | $28.25 mm |